期刊文献+

人细胞周期蛋白D1/CDK4基因的真核表达及生物活性鉴定 被引量:2

Expression and Activity Identification of Human Cyclin D1 and CDK4 Gene in Insect Expression System
下载PDF
导出
摘要 通过生物工程获得人重组细胞周期蛋白 (cyclinD1 )及细胞周期蛋白激酶CDK4蛋白 ,作为抗癌药物筛选的分子靶点 .从人HL 6 0细胞中获得细胞周期蛋白D1 CDK4基因的cDNA ,先克隆至pGEMT Easy载体上 ,再经重组构建供体质粒pFastBac D1和pFastBac CDK4 .重组供体质粒转化感受态DH1 0Bac细胞 ,挑取确证为白色克隆的菌落振荡培养 ,分离制备高纯度杆粒DNA .以重组病毒适量感染昆虫细胞Tn 5B1 4 ,利用Bac to Bac杆状病毒表达系统在昆虫细胞Tn 5B1 4 (Hi5 )中表达相应的重组蛋白 .应用昆虫杆状病毒表达系统 (Bac to Bac)在昆虫细胞Tn 5B1 4中分别高效表达了人细胞周期蛋白D1和CDK4蛋白 .SDS PAGE分析表明 ,表达量占细胞可溶性蛋白质的 2 0 %左右 ,表达产物经Ni2 + NTA亲和层析纯化后纯度达 85 %以上 .研究表明 ,昆虫细胞表达的细胞周期蛋白D1和CDK4蛋白能促进Rb蛋白的磷酸化 ,具有生物活性 .成功构建了细胞周期蛋白D1及CDK4真核杆状病毒表达载体 ,并且在昆虫细胞中正确表达了具有生物活性的细胞周期蛋白D1及CDK4融合蛋白 . Cyclin D1 and CDK4 fusion proteins were used in antiproliferative inhibitor screening. Cyclin D1 and CDK4 genes were obtained by RT PCR from HL 60 cells and inserted into pGEM T Easy vector. The genes were released from T vector by endonuclease and insered into insect baculovirus donor plasmid. Recombinant vectors were identified by restriction enzyme cutting and homologues recombination in E coli DH10Bac. Recombinant bacmid DNA was transformed into insect cell Tn 5B1 4. The proteins were identified by SDS PAGE and Western blotting. The activity of Cyclin D1/CDK4 was detected by phosphorylation of GST Rb in kinase assay. The insect expressing vectors could express Cyclin D1 and CDK4 proteins which possessed ability of phosphorylating Rb protein, showing biological activity. Cyclin D1 and CDK4 proteins were expressed correctly in insect cells and had their biological activity.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2003年第6期709-714,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金 (No:3 0 10 0 2 2 7) 国家 863课题 (No :2 0 0 1AA2 3 40 11) 中山医科大学"2 11工程"肿瘤学重点学科基金 (No :980 69)联合资助~~
关键词 细胞周期蛋白D1 昆虫杆状病毒表达系统 分子靶点 真核表达 基因表达 生物活性 cyclin D1,CDK4,baculovirus expression system, molecular target
  • 相关文献

参考文献7

  • 1[1]Sherr C J. Cancer cell cycles. Science, 1996, 274: 1672~1677
  • 2[2]Buolamwini J K. Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des, 2000,6(4):379~392
  • 3[3]Stillman B. Cell cycle control of DNA replication. Science,1996,274: 1659 ~1664
  • 4[4]Morgan D O. Principles of CDK regulation. Nature,1995,374: 131~134
  • 5[5]Kelland L R. Flavopiridol,the first cyclin-dependent kinase inhibitor to enter the clinic: Current status. Expert Opin Investig Drugs,2000,9(12):2903~2911
  • 6[6]Rao R N. Targets for cancer therapy in the cell cycle pathway. Curr Opin Oncol, 1996,8: 516~524
  • 7[7]Matsushime H, Quelle D E, Shurtleff S A, Shibuya M, Sherr C J, Kato J Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol, 1994, 14(3): 2066~2076

同被引文献29

  • 1黄孝春,郭跃伟.海绵药物的研究进展:化学和生物活性[J].中国天然药物,2005,3(1):1-9. 被引量:11
  • 2张娜,蒋勇军,邹建卫,曾敏,胡桂香,俞庆森.CDK4与靛玉红及其衍生物复合物结构的模建[J].化学学报,2005,63(9):809-813. 被引量:7
  • 3李桂英,邹德生,周立宏,曹玉华.人细胞周期蛋白D1在大肠杆菌BL21中的表达及纯化[J].吉林大学学报(理学版),2006,44(5):839-843. 被引量:1
  • 4Radchenko OS, Vyacheslav L, Novikov, et al. A simple and practical approach to the synthesis of the marine sponge pigmenffascaplysin and relates compounds. Tetrahedron Letters, 1997,38:5339 -5342.
  • 5Lin J(林晶),Yan XJ(严小军),Chen HM(陈海敏).Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo. Cancer Chemotherapy and Pharmacology,2007,59:439-445.
  • 6Fischer PM. Functions and pharmacological inhibitors of cyclin-dependent kinases ( CDKs ). Celltransmissions, 2003,19 : 3-9.
  • 7Aubry C, Patel A, Mahale S, et al. The design and synthesis of novel 3-[2-indol-t-yl-ethyl]-lHindole derivatives as selective inhibitors of CDK4. Tetrahedron Letters, 2005,46: 1423-1425.
  • 8Hormann A,Chauduri B. DNA binding properties of the marine sponge pigment faseaplysin. Bioorganic & Medicinial Chemistry,2001,9:917-921.
  • 9Pelcman B, Gordon W. ,Gribble. Total synthesis of the marine sponge pigment fascaplysin. Tetrahedron Letter, 1990, 51: 2381-2384.
  • 10Rocca P, Marsais F, Godard A, et al. A short sythesis of the antimicrobial marine sponge pigment fascaplysin. Tetrahedron Letter, 1993,34:7917-7918.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部